Supreme Court denies Novartis patent for cancer drug

  • 20:01
  • Published On: April 01, 2013
Cinema View
Embed
The Supreme Court has dismissed Swiss drugmaker Novartis AG's attempt to win patent protection for its cancer drug Glivec, a serious blow to Western pharmaceutical firms who are increasingly focusing on India to drive sales.

Related Videos

Fake Cancer, Liver Drugs In Market: Who Is Playing With Lives?
September 12, 2023 50:59
WHO Flags Counterfeit Cancer, Liver Medication
September 11, 2023 2:49
Government to Slash Prices of Over 100 Drugs; Pharma Firms Call it 'Flawed'
July 15, 2014 2:13
Novartis verdict fallout: Patents vs patients?
April 06, 2013 50:44
Novartis ruling shows India doesn't want innovation: Peter Pitts
April 03, 2013 3:55
The 9 O'clock News: The biggest stories (April 2, 2013)
April 02, 2013 50:15
Patent war: patients vs profit?
April 02, 2013 35:39
Money Mantra: Analysis Supreme Court’s verdict on Novartis
April 02, 2013 50:02
Supreme Court backs generics in Novartis drug patent ruling
April 01, 2013 2:23
Money Mantra: What measures can be taken to fight cancer
April 17, 2012 45:43
Our Offerings: NDTV
  • मध्य प्रदेश
  • राजस्थान
  • इंडिया
  • मराठी
  • 24X7
Choose Your Destination